BioVentrix is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
BioVentrix is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
BioVentrix is a medical device company developing and commercializing less invasive therapies for patients with heart failure caused by ischemic cardiomyopathy, using its Revivent TC™ System.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.